Charge transport processes in nonconjugated redox-active polymers with electrolytes were studied using a diffusion-cooperative model. For the first time, we quantitatively rationalized that the limited Brownian motion of the redox centers bound to the polymers resulted in the 10-fold decline of the bimolecular and heterogeneous charge transfer rate constants, which had been unexplained for half a century. As a next-generation design, a redox-active supramolecular system with high physical mobility was proposed to achieve the rate constant as high as in free solution system (>10 M s) and populated site density (>1 mol/L).
A supramolecular
gelator, 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO)-substituted
cyclohexanediamine derivative, was synthesized, and its excellent
charge-transporting capability was explored. The gels with organic
solvents and electrolytes, or with ionic liquids, were formed via
reversible sol–gel phase transition at ca. 50 °C. The
organogels displayed electrochemical redox responses at E
1/2 = 0.72 V (vs Ag/AgCl) ascribed to the TEMPO moiety.
Charge diffusion coefficient of the gel reached 3.3 × 10–7 cm2/s even in the quasi-solid state, which
was comparable to those of the homogeneous solution (ca. 10–6). The high charge-transporting capability led to the tremendously
large current density (a diffusion limited one) of ca. 1.0 mA/cm2 on a current collector and long distance for the charge-transporting
beyond the organogel thickness of 50 μm. A half-cell of the
organogel performed a plateau output voltage at the E
1/2, very high rate, and almost quantitative charging–discharging,
and it had cyclability without any additives such as conductive carbons
and binder polymers.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.